<?xml version='1.0' encoding='utf-8'?>
<document id="27998705"><sentence text="In Vitro-In Vivo Extrapolation of Intestinal Availability for Carboxylesterase Substrates Using Portal Vein-Cannulated Monkey." /><sentence text="Prediction of intestinal availability (FaFg) of carboxylesterase (CES) substrates is of critical importance in designing oral prodrugs with optimal properties, projecting human pharmacokinetics and dose, and estimating drug-drug interaction potentials" /><sentence text=" A set of ester prodrugs were evaluated using in vitro permeability (parallel artificial membrane permeability assay and Madin-Darby canine kidney cell line-low efflux) and intestinal stability (intestine S9) assays, as well as in vivo portal vein-cannulated cynomolgus monkey"><entity charOffset="10-15" id="DDI-PubMed.27998705.s3.e0" text="ester" /></sentence><sentence text=" In vitro-in vivo extrapolation (IVIVE) of FaFg was developed with a number of modeling approaches, including a full physiologically based pharmacokinetic (PBPK) model as well as a simplified competitive-rate analytical solution" /><sentence text=" Both methods converged as in the PBPK simulations enterocyte blood flow behaved as a sink, a key assumption in the competitive-rate analysis" /><sentence text=" For this specific compound set, the straightforward analytical solution therefore can be used to generate in vivo predictions" /><sentence text=" Strong IVIVE of FaFg was observed for cynomolgus monkey with R2 of 0" /><sentence text="71-0" /><sentence text="93" /><sentence text=" The results suggested in vitro assays can be used to predict in vivo FaFg for CES substrates with high confidence" /><sentence text="" /></document>